GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Long-Term Debt

NFL Biosciences (XPAR:ALNFL) Long-Term Debt : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Long-Term Debt?

NFL Biosciences's Long-Term Debt for the quarter that ended in Dec. 2023 was €0.00 Mil.

NFL Biosciences's quarterly Long-Term Debt increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.07 Mil) but then declined from Jun. 2023 (€0.07 Mil) to Dec. 2023 (€0.00 Mil).


NFL Biosciences Long-Term Debt Historical Data

The historical data trend for NFL Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Long-Term Debt Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Debt Get a 7-Day Free Trial - 0.07 - 0.07 -

NFL Biosciences  (XPAR:ALNFL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


NFL Biosciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines